Bayer S.A. (Peru) engages in the pharmaceuticals, consumer health, and crop science businesses in Peru. It operates through three segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment engages in development, production, and marketing of products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. Its Pharmaceutical segment develops, produces, and markets prescription products for cardiology and women’s health; oncology, hematology, ophthalmology, and medium-term cell and gene therapy; and diagnostic imaging equipment, and contrast agents. The Consumer Health segment is involved in development, production, and marketing of nonprescription over-the-counter products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded in 1947 and is based in Lima, Peru. Bayer S.A. (Peru) operates as a subsidiary of Bayer Gesellschaft für Beteiligungen mbH.